Techno Medica Co., Ltd. (TYO:6678)
2,048.00
+53.00 (2.66%)
Aug 6, 2026, 12:34 PM JST
Techno Medica Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 13,900 | 16,297 | 12,162 | 12,244 | 15,974 | 13,303 | |
Market Cap Growth | 4.47% | 34.00% | -0.67% | -23.35% | 20.08% | -6.58% |
Enterprise Value | 4,924 | 7,552 | 3,213 | 4,186 | 4,743 | 2,191 |
Last Close Price | 1995.00 | 2339.00 | 1662.22 | 1614.09 | 1663.59 | 1327.26 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 12.86 | 15.23 | 12.11 | 9.08 | 13.89 | 10.39 |
PS Ratio | 1.24 | 1.45 | 1.23 | 1.19 | 1.71 | 1.37 |
PB Ratio | 0.96 | 1.13 | 0.85 | 0.89 | 0.98 | 0.85 |
P/TBV Ratio | 0.97 | 1.14 | 0.85 | 0.89 | 0.98 | 0.85 |
P/FCF Ratio | 13.05 | 15.30 | 12.78 | 11.08 | 21.19 | 6.67 |
P/OCF Ratio | 12.64 | 14.82 | 12.45 | 10.72 | 18.01 | 6.45 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.44 | 0.67 | 0.32 | 0.41 | 0.51 | 0.23 |
EV/EBITDA Ratio | 2.80 | 4.29 | 2.30 | 2.14 | 2.70 | 1.12 |
EV/EBIT Ratio | 2.95 | 4.53 | 2.47 | 2.28 | 2.88 | 1.19 |
EV/FCF Ratio | 4.62 | 7.09 | 3.38 | 3.79 | 6.29 | 1.10 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Debt / Equity Ratio | -0.62 | -0.62 | -0.63 | -0.62 | -0.72 | -0.74 |
Net Debt / EBITDA Ratio | -5.10 | -5.10 | -6.48 | -4.40 | -6.69 | -5.89 |
Net Debt / FCF Ratio | -8.43 | -8.43 | -9.52 | -7.77 | -15.58 | -5.77 |
Asset Turnover | 0.63 | 0.63 | 0.56 | 0.56 | 0.49 | 0.54 |
Inventory Turnover | 2.45 | 2.45 | 2.09 | 2.55 | 3.06 | 3.40 |
Quick Ratio | 4.33 | 4.33 | 3.97 | 3.84 | 5.48 | 5.77 |
Current Ratio | 5.09 | 5.09 | 4.79 | 4.49 | 6.16 | 6.26 |
Return on Equity (ROE) | 7.43% | 7.43% | 7.12% | 8.93% | 7.18% | 8.37% |
Return on Assets (ROA) | 5.81% | 5.81% | 4.59% | 6.24% | 5.43% | 6.37% |
Return on Invested Capital (ROIC) | 20.98% | 21.76% | 18.74% | 27.03% | 25.99% | 28.43% |
Return on Capital Employed (ROCE) | 11.20% | 11.20% | 8.90% | 13.10% | 9.90% | 11.60% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 7.70% | 6.57% | 8.25% | 11.01% | 7.20% | 9.63% |
FCF Yield | 7.66% | 6.54% | 7.83% | 9.03% | 4.72% | 15.00% |
Payout Ratio | 44.02% | 44.02% | 46.81% | 37.69% | 43.91% | 33.88% |
Buyback Yield / Dilution | 0.40% | 0.40% | 11.17% | 7.64% | 0.64% | -0.01% |